In addition, while TGF-β1 production in breast cancer cells was elevated after peritoneal macrophage conditioned medium (PMCM) treatment, emodin significantly reduced baseline and PMCM-induced TGF-β1 production in cancer cells (Figure 2E). The gene discussed is TGFB1; the disease is breast carcinoma.